Rosecliff Acquisition I (MDAI) Directors and Executive Officers - CSIMarket
CSIMarket
 
Rosecliff Acquisition Corp I  (NASDAQ: MDAI)

Rosecliff Acquisition Corp I

Officers & Directors


Cynthia Cai, Director

J. Michael DiMaio, Director

Deepak Sadagopan, Director

Richard Cotton, Chairman of the Board of Directors

Martin Mellish, Director

Peter M. Carlson, Director and Chief Executive Officer

Erich Spangenberg, Director

Vincent Capone, Chief Financial Officer,

Rosecliff Acquisition Corp I currently has 65 employees.

  News about Rosecliff Acquisition Corp I Key Personnel

Spectral AI Unveils Software Upgrades for Enhanced Diagnostic Precision, Following Clinician Feedback Amid Strategic Financial Moves,

IntroductionIn a recent development signaling its commitment to advancing medical diagnostics, Spectral AI (NASDAQ: MDAI) has announced significant software enhancements to its DeepView SnapShot M and DeepView AI-Burn systems targeted at improving diagnostic precision in wound care. These improvements, highlighted in a release on December 9, 2024, are the culmination of insights gained from frontline feedback from clinicians operating in critical care settings in the UK.Key Enhancements to Diagnostic SoftwareThe software updates were designed specifically to boost product performance and usability for healthcare professionals. By incorporating real-world experiences, Spectral AI aims to refine its technology...

Spectral AI Achieves Milestone in Burn Treatment Study While Facing Financial Challenges

In a significant development for the healthcare sector, Spectral AI, Inc. (NASDAQ: MDAI), a pioneering artificial intelligence company focused on enhancing medical diagnostics for wound care, has reported a notable milestone in its U.S. Burn Pivotal Study. As of September 24, 2024, the company has successfully enrolled 25% of its target patient population at various emergency departments (EDs), reflecting a promising step forward in its clinical research efforts.The company has expanded its clinical trial footprint by adding two new ED sites, MedStar Washington Hospital Center in Washington, DC, under the guidance of Principal Investigator Dr. Shawn Tejiram, and the University of Utah, led by Principal Inves...

Bridging the Gap: Spectral AI's DeepView System Seeks to Transform Burn Care Accessibility Amid Financial Headwinds




Bridging the Gap: Spectral AI s DeepView System Seeks to Transform Burn Care Accessibility Amid Financial Headwinds
In an era where technological advancements are reshaping the landscape of healthcare, Spectral AI, Inc. (Nasdaq: MDAI) is positioned at the forefront with its innovative DeepView AI-Burn system. Announced on September 17, 2024, the company s outlined regulatory strategy aims to facilitate the entry of this cutting-edge diagnostic tool into the U.S. market specifically for burn care indications. However, beneath this promising advancement lies a complex web of financial struggles that could complicate its mission to promote equitable access to essential burn treatment service...

Disparities in Burn Care Access: A Tale of Technology, Funding, and Financial Resiliencenn



Unequal Scars - Unpacking Access to Burn Care in Americann
The recent American Burn Association study has revealed deep-rooted inequities in access to specialized burn care across the United States, highlighting a significant gap that leaves vulnerable populations without the life-saving treatment they need. As this crisis unfolds, innovative technology like Spectral AIs DeepView System proposes a solution, aiming to promote equitable access to burn care while simultaneously optimizing healthcare resources. However, the financial landscape for companies spearheading this change paints a complex picture.
Spectral AI, a player in the healthcare technology sphere, is striving to innovate sol...

Spectral AI Announces Strong Support from Stockholders in 2024 Annual Meeting and Appointment of New Board Member


In a significant development for Spectral AI, Inc. (NASDAQ: MDAI), the company recently conducted its much-anticipated Annual Meeting of Stockholders on May 14, 2024. Spectral AI, a prominent artificial intelligence (AI) firm specializing in medical diagnostics for wound care, unveiled the outcomes of the meeting along with an important addition to its Board of Directors.
During the AGM, all four proposals put forth by Spectral AI received overwhelming approval from the stockholders. This resounding endorsement demonstrates the investors faith in the company s vision and strategic plans. The shareholders support is particularly noteworthy as Spectral AI s cutting-edge AI technology holds immense p...






MDAI Management Effectiveness MDAI Revenue per Employee MDAI Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.